UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value

Blood, 2007-07, Vol.110 (1), p.433-440

2007

Volltextzugriff (PDF)

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo

The Journal of clinical investigation, 2009-05, Vol.119 (5), p.1251-1263

2009

Volltextzugriff (PDF)

Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants

Science (American Association for the Advancement of Science), 2002-03, Vol.295 (5562), p.2097-2100

2002

Volltextzugriff (PDF)

Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia

Arteriosclerosis, thrombosis, and vascular biology, 2006-11, Vol.26 (11), p.2530-2535

2006

Volltextzugriff (PDF)

Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation

Blood, 1999-07, Vol.94 (1), p.333-339

1999

Volltextzugriff (PDF)

Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer

Current opinion in immunology, 2005-04, Vol.17 (2), p.211-217

2005

Volltextzugriff (PDF)

Natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation

International journal of hematology, 2005-01, Vol.81 (1), p.13-17

2005

Volltextzugriff (PDF)

Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1

Blood, 2008-08, Vol.112 (3), p.708-710

2008

Volltextzugriff (PDF)

Preclinical characterization of 1-7F9, a novel human anti–KIR receptor therapeutic antibody that augments natural killer–mediated killing of tumor cells

Blood, 2009-09, Vol.114 (13), p.2667-2677

2009

Volltextzugriff (PDF)

Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation

Blood, 2005-12, Vol.106 (13), p.4397-4406

2005

Volltextzugriff (PDF)

NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation

Blood cells, molecules, & diseases, 2008, Vol.40 (1), p.84-90

2008

Volltextzugriff (PDF)

Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk

Atherosclerosis, 2008-04, Vol.197 (2), p.757-767

2008

Volltextzugriff (PDF)

Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype–mismatched hematopoietic transplants

Blood, 2001-04, Vol.97 (8), p.2514-2521

2001

Volltextzugriff (PDF)

Expansion of CD56-Negative, CD16-Positive, KIR-Expressing Natural Killer Cells after T Cell-Depleted Haploidentical Hematopoietic Stem Cell Transplantation

Acta haematologica, 2011-01, Vol.126 (1), p.13-20

2011

Volltextzugriff (PDF)

Selecting Haploidentical Transplant Donors for Deploying Optimal NK Cell Allotherapy

Blood, 2009-11, Vol.114 (22), p.511-511

2009

Volltextzugriff (PDF)

Cellular therapy: exploiting NK cell alloreactivity in transplantation

Current opinion in hematology, 2001-11, Vol.8 (6), p.355-359

2001

Volltextzugriff (PDF)

The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation

Transplant Immunology, 2005-08, Vol.14 (3), p.203-206

2005

Volltextzugriff (PDF)

Anti-KIR (1-7F9): A Fully Human Monoclonal Antibody (mAb) That Blocks KIR2DL1, −2 and −3, Promoting Natural Killer (NK) Cell-Mediated Lysis of Tumor Cells In Vitro and In Vivo

Blood, 2007-11, Vol.110 (11), p.582-582

2007

Volltextzugriff (PDF)

Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation

Blood cells, molecules, & diseases, 2004-11, Vol.33 (3), p.216-221

2004

Volltextzugriff (PDF)

Alloreactive Natural Killer Cells Rebuild Adaptive Immunity to Infections after Haploidentical Hematopoietic Transplantation

Blood, 2006-11, Vol.108 (11), p.3210-3210

2006

Volltextzugriff (PDF)

Donor Natural Killer Cell Allorecognition of Missing Self in Haploidentical Hematopoietic Transplantation for Acute Myeloid Leukemia: Challenging Its Predictive Value

Blood, 2006-11, Vol.108 (11), p.437-437

2006

Volltextzugriff (PDF)

Natural killer cells as a therapeutic tool in mismatched transplantation

Best practice & research. Clinical haematology, 2004-09, Vol.17 (3), p.427-438

2004

Volltextzugriff (PDF)

Natural killer cell-mediated lysis of autologous cells modified by gene therapy

The Journal of experimental medicine, 1999-06, Vol.189 (12), p.1855-1862

1999

Volltextzugriff (PDF)

Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Commentary

Blood, 2005, Vol.106 (13)

2005

Volltextzugriff (PDF)

Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation

The hematology journal : the official journal of the European Haematology Association, 2004, Vol.5 Suppl 3, p.S87-S90

2004

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value

NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo

Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants

Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia

Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation

Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer

Natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation

Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1

Preclinical characterization of 1-7F9, a novel human anti–KIR receptor therapeutic antibody that augments natural killer–mediated killing of tumor cells

Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation

NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation

Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk

Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype–mismatched hematopoietic transplants

Expansion of CD56-Negative, CD16-Positive, KIR-Expressing Natural Killer Cells after T Cell-Depleted Haploidentical Hematopoietic Stem Cell Transplantation

Selecting Haploidentical Transplant Donors for Deploying Optimal NK Cell Allotherapy

Cellular therapy: exploiting NK cell alloreactivity in transplantation

The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation

Anti-KIR (1-7F9): A Fully Human Monoclonal Antibody (mAb) That Blocks KIR2DL1, −2 and −3, Promoting Natural Killer (NK) Cell-Mediated Lysis of Tumor Cells In Vitro and In Vivo

Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation

Alloreactive Natural Killer Cells Rebuild Adaptive Immunity to Infections after Haploidentical Hematopoietic Transplantation

Donor Natural Killer Cell Allorecognition of Missing Self in Haploidentical Hematopoietic Transplantation for Acute Myeloid Leukemia: Challenging Its Predictive Value

Natural killer cells as a therapeutic tool in mismatched transplantation

Natural killer cell-mediated lysis of autologous cells modified by gene therapy

Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Commentary

Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation

Suchergebnisse filtern